The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-06-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.0403495101PMID 15210960PMCID PMC470762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome

  2003cited by this paper
• Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non‐desensitizing AMPA receptors in hippocampal cultures

  2003cited by this paper
• 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.

  2003cited by this paper
• Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

  2003cited by this paper
• An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators.

  2003cited by this paper
• Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.

  2003cited by this paper
• Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.

  2003cited by this paper
• Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease

  2003cited by this paper
• Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.

  2003cited by this paper
• The structure of neuromelanin as studied by chemical degradative methods

  2003cited by this paper
• Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.

  2002cited by this paper
• Copper-containing monooxygenases: enzymatic and biomimetic studies of the O-atom transfer catalysis.

  2002cited by this paper
• Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury

  2002cited by this paper
• The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

  2002cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease

  2001cited by this paper
• MPTP: a review of its mechanisms of neurotoxicity

  2001cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease.

  2001cited by this paper
• Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

  2001cited by this paper
• Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

  2001cited by this paper
• Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

  2000cited by this paper
• Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides

  2000cited by this paper
• Changes of copper‐transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult‐onset dystonia

  2000cited by this paper
• Manganese intoxication.

  2000cited by this paper
• FEBS Lett

  2000cited by this paper
• MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies

  2000cited by this paper
• Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure

  1999cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.

  1997cited by this paper
• Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.

  1996cited by this paper
• Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.

  1996cited by this paper
• A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains

  1995cited by this paper
• Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

  1995cited by this paper
• The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.

  1995cited by this paper
• Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain

  1994cited by this paper
• Total and paramagnetic metals in human substantia nigra and its neuromelanin

  1993cited by this paper
• Disease‐specific patterns of locus coeruleus cell loss

  1992cited by this paper
• The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

  1991cited by this paper
• Superoxide dismutase-like activity in the Parkinson's disease brain.

  1990cited by this paper
• Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression

  1989cited by this paper
• A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper
• Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin.

  1988cited by this paper
• Noradrenergic mechanisms in age-related cognitive decline.

  1987cited by this paper
• Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

  1986cited by this paper
• Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase

  1979cited by this paper
• A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord.

  1977cited by this paper
• Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex.

  1975cited by this paper
• Chronic manganese intoxication.

  1974cited by this paper
• Studies on neuromelanin: II. Melanin in the brainstems of infants and children

  1968cited by this paper

• Cerebral iron deposition in the Globus pallidus and Substantia nigra of aging dogs and cats presenting as bilateral hypointensity on T2w and iron-sensitive MRI sequences (SWI, T2*).

  2026cites this paper
• Copper, Ceruloplasmin, Zinc, and Manganese Levels in Brain and Biological Fluids from Parkinson’s Disease Patients: Systematic Review and Meta-Analysis

  2026cites this paper
• Neuromelanin, iron and MRI measurements in midbrain tissues of Parkinson's and Alzheimer's subjects.

  2026cites this paper
• Sources of Oxidative Stress in Parkinson's Disease: Pathways and Therapeutic Implications.

  2026cites this paper
• Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration

  2025cites this paper
• The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression

  2025cites this paper
• Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer’s Disease

  2025cites this paper
• Evaluating Parkinson’s disease biomarkers in substantia nigra following sublethal γ-radiation exposure in a large animal model

  2025cites this paper
• Neonatal sevoflurane exposures inhibits DHHC5-mediated palmitoylation of TfR1 in oligodendrocytes, leading to hypomyelination and neurological impairments

  2025cites this paper
• Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin‐sensitive imaging

  2025cites this paper
• Carbon nanotube field-effect transistor immunosensor for the real-time detection of serum ferritin, a biomarker of Alzheimer's disease

  2025cites this paper
• Hemispheric Asymmetry of Neuromelanin‐Iron Dysfunction in the Substantia Nigra: MRI‐Based Evidence for Lateralized Motor Onset in Early‐Stage Parkinson's Disease

  2025influential citation
• The Role of the LC-NE System in Attention: From Cells, to Systems, to Sensory-Motor Control.

  2025cites this paper
• Neuromelanin-targeted 18F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques

  2025cites this paper
• Blunted response of caudal locus coeruleus to arousing stimuli in Parkinson’s Disease

  2025cites this paper
• Reduced Brain Iron is Associated with Striatal Hyperdopaminergia in Schizophrenia and Unrelated to Neuromelanin and Myelin Imaging Measures: A Quantitative Susceptibility Mapping MRI and PET Study

  2025cites this paper
• Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan

  2025influential citation
• Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections

  2025cites this paper
• Cerebrospinal fluid catecholamines levels in Alzheimer's disease, frontotemporal dementia, and normal controls.

  2025cites this paper
• Modellierung von Neuromelanin des Mittelhirns und Hirnstamms zur Charakterisierung der Metallbindung und des damit verbundenen MRT‐Kontrasts bei der Parkinson‐ und Alzheimer‐Krankheit

  2025cites this paper
• Redox System Dysfunction as a Key Mechanism in Autism Spectrum Disorder Pathogenesis

  2025cites this paper
• Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases

  2025cites this paper
• Convergence of Cannabis and Psychosis on the Dopamine System

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• Nigrostriatal iron accumulation in the progression of Parkinson’s disease

  2025cites this paper
• Age-related differences in Rostral-Middle locus coeruleus microstructure: A critical role in cognitive decline revealed by magnetic resonance relaxometry

  2025cites this paper
• Impact of Alzheimer’s disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleus

  2025cites this paper
• Neuromelanin and selective neuronal vulnerability to Parkinson's disease.

  2025influential citation
• Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies

  2025cites this paper
• High-resolution mapping of substantia nigra in Parkinson’s disease using 7 tesla magnetic resonance imaging

  2025cites this paper
• Excess iron may accelerate amyloid beta accumulation in the brains of older mice.

  2025cites this paper
• Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits

  2024cites this paper
• Empirically derived formulae for calculation of age- and region-related levels of iron, copper and zinc in the adult C57BL/6 mouse brain.

  2024influential citation
• The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.

  2024cites this paper
• Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease.

  2024cites this paper
• Ultrastructural and chemical analysis of human Locus coeruleus using correlative microscopy and mass spectrometry

  2024cites this paper
• Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson’s disease

  2024cites this paper
• Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-sensitive MRI and [18F]-DOPA PET Study.

  2024cites this paper
• Detection of molecular markers of ferroptosis in human Alzheimer's disease brains

  2024cites this paper
• RETRACTED ARTICLE: Neuromelanin-targeted 18 F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques

  2024cites this paper
• New opportunities for antioxidants in amelioration of neurodegenerative diseases.

  2024cites this paper
• HFE Mutations in Neurodegenerative Disease as a Model of Hormesis

  2024cites this paper
• The Role of Glia in Wilson’s Disease: Clinical, Neuroimaging, Neuropathological and Molecular Perspectives

  2024cites this paper
• Soft modeling strategies at work to follow and rationalize dopamine oxidative polymerization

  2024cites this paper
• Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry

  2024cites this paper
• Protective and Damaging Mechanisms of Neuromelanin‐Like Nanoparticles and Iron in Parkinson's Disease

  2024cites this paper
• Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials

  2024cites this paper
• Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

  2024cites this paper
• The characteristic patterns of individual brain susceptibility networks underlie Alzheimer’s disease and white matter hyperintensity-related cognitive impairment

  2024cites this paper
• Comparison of 3D Magnetization-transfer- and Spectral-presaturation-with-inversion-recovery-based Neuromelanin Imaging

  2024influential citation
• Exploiting Principal Component Analysis (PCA) to reveal temperature, buffer and metal ions' role in neuromelanin (NM) synthesis by dopamine (DA) oxidative polymerization.

  2024cites this paper
• Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis

  2024influential citation
• Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects

  2024cites this paper
• Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations.

  2024cites this paper
• Automatic geometry-based estimation of the locus coeruleus region on T1-weighted magnetic resonance images

  2024cites this paper
• Changes in the locus coeruleus during the course of Alzheimer's disease and their relationship to cortical pathology

  2024cites this paper
• Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• Interactive effects of locus coeruleus structure and catecholamine synthesis capacity on cognitive function

  2023cites this paper
• Neuromelanin? MRI of catecholaminergic neurons.

  2023cites this paper
• Non-invasive assessment of normal and impaired iron homeostasis in the brain

  2023cites this paper
• Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?

  2023cites this paper
• Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer

  2023cites this paper
• Title Locus coeruleus integrity predicts ease of attaining and maintaining neural states of high attentiveness Authors and Affiliations

  2023cites this paper
• Noradrenergic neuromodulation in ageing and disease.

  2023cites this paper
• The toxic metal hypothesis for neurological disorders

  2023cites this paper
• An Update Overview on Mechanistic Data and Biomarker Levels in Cobalt and Chromium-Induced Neurodegenerative Diseases

  2023cites this paper
• Iron homeostasis imbalance and ferroptosis in brain diseases

  2023cites this paper
• Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target.

  2023cites this paper
• Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

  2023cites this paper
• Recent Advances in Characterization of Melanin Pigments in Biological Samples

  2023cites this paper
• Locus coeruleus integrity predicts ease of attaining and maintaining neural states of high attentiveness

  2023cites this paper
• Rutin, Puerarin and Silymarin Regulated Aluminum-Induced Imbalance of Neurotransmitters and Metal Elements in Brain of Rats

  2023cites this paper
• Effect of age on substantia nigra subregions using neuromelanin-sensitive magnetic resonance imaging overlapping on quantitative susceptibility mapping

  2023cites this paper
• In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohorts

  2023cites this paper
• Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease.

  2023cites this paper
• Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function.

  2023cites this paper
• Parkin coregulates glutathione metabolism in adult mammalian brain

  2023cites this paper
• The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis

  2023cites this paper
• Copper drives prion protein phase separation and modulates aggregation

  2023cites this paper
• Iron Level Changes in the Brain with Neurodegenerative Disease

  2023cites this paper
• Chemiexcitation: Mammalian Photochemistry in the Dark†

  2023cites this paper
• Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus

  2023cites this paper
• DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.

  2023cites this paper
• The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease

  2023cites this paper
• Non-invasive assessment of normal and impaired iron homeostasis in living human brains

  2023cites this paper
• Riddles in the Dark: Decoding the Relationship Between Neuromelanin and Neurodegeneration in Locus Coeruleus Neurons.

  2023cites this paper
• The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance

  2023cites this paper
• DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease and it exacerbates alpha-synuclein neurotoxicity

  2022cites this paper
• Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and neurodegeneration with brain iron accumulation disorders.

  2022cites this paper
• The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies

  2022cites this paper
• Sandwich spatial saturation for neuromelanin-sensitive MRI: Development and multi-center trial

  2022cites this paper
• Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease

  2022cites this paper
• High cortical iron is associated with the disruption of white matter tracts supporting cognitive function in healthy older adults

  2022cites this paper
• Adaptive cellular response of the substantia nigra dopaminergic neurons upon age‐dependent iron accumulation

  2022influential citation
• Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis

  2022cites this paper
• ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism

  2022cites this paper
• Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging

  2022cites this paper
• Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target

  2022cites this paper
• Cerebral Iron Deposition in Neurodegeneration

  2022cites this paper
• Intracerebral Hemorrhage: The Effects of Aging on Brain Injury

  2022cites this paper